Marlies Wijsenbeek

基本信息

浏览量：129

职业迁徙

个人简介

Her research interests include e-health, patient-centred outcome measures in ILD, cough in ILD and new therapies in ILD and sarcoidosis.

Dr Wijsenbeek is chair of group 12.01 (IIP) of the European Respiratory Society, chair of the functional committee for continued education of the ERN-Lung, member of the scientific advisory board of the European Idiopathic Pulmonary Fibrosis & Related Disorders Federation, and Associate Editor of the European Respiratory Journal.

研究兴趣

论文共 334 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effect of BI 1015550, a Preferential PDE4B Inhibitor, on FEV1/FVC Ratio in IPF

Vincent Cottin,Arata Azuma,Toby M. Maher,Claudia Valenzuela,Marlies S. Wijsenbeek, Yi Liu,Susanne Stowasser,Donald F. Zoz,Luca Richeldi

Pneumologie (2024)

引用0浏览0引用

An Adjudication Algorithm for Respiratory-Related Hospitalisation in IPF

Paul Ford,Michael Kreuter,Kevin K. Brown,Wim Wuyts,Marlies Wijsenbeek, Dominique Israëł-Biet,Richard Hubbard,Steven D. Nathan,Hilario Nunès, Björn Penninckx,Niyati Prasad,Ineke Seghers,Paolo Spagnolo,Nadia Verbruggen,Nikhil Hirani, Jürgen Behr,Robert J. Kaner,Toby M. Maher

ERJ open researchpp.00636-2023, (2024)

引用0浏览0引用

Associations Entre Les Scores De Dyspnée Du Questionnaire L-PF Et Les Résultats Chez Des Patients Présentant Une Pneumopathie Interstitielle Diffuse Fibrosante Progressive : Données De L’essai INBUILD

M.S. Wijsenbeek, P. Spagnolo,M. Kolb,M. Kreuter,H. Nunes,W. Stansen,K.B. Rohr, Y. Inoue

Revue des Maladies Respiratoires Actualités（2024）

引用0浏览0引用

Meta-analysis of Effect of Nintedanib on Mortality in Subjects with Idiopathic Pulmonary Fibrosis (IPF) and Other Forms of Progressive Pulmonary Fibrosis (PPF)

D. Koschel,W. Wuyts,T. Maher,M. Wijsenbeek,F. Martinez,W. Stansen,S. Stowasser,L. Richeldi

PNEUMOLOGIE (2024): S81-S82

引用0浏览0引用

A Modified Delphi Exercise in Physician-Perceived Risk Factors for Drug-Induced Pneumotoxicity in Patients with Rheumatological Disease

Manjit K. Cartlidge, Kevin K. Brown,Nazia Chaudhuri, Tamera J. Corte, Phillipe Dieudé, Levin John,Clive Kelly,Dinesh Khanna, Euan McRorie,Lisa Nicol, Gareth Stewart, Simon L. F. Walsh,Marlies Wijsenbeek,Nik Hirani

BMC Pulmonary Medicineno. 1 (2024): 1-9

引用0浏览0WOS引用

Is YouTube a Sufficient Source of Information on Sarcoidosis

Katharina Buschulte, Sarah El-Hadi,Philipp Höger,Claudia Ganter,Marlies Wijsenbeek,Nicolas Kahn,Katharina Kriegsmann,Gillian C. Goobie,Christopher J. Ryerson,Markus Polke,Franziska Trudzinski,Michael Kreuter

Respiratory Researchno. 1 (2024): 1-9

引用0浏览0WOS引用

Study Design of BI 1015550 for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: a Plain Language Summary

Toby M. Maher, Arata Azuma,Vincent Cottin,Shervin Assassi, Anna‐Maria Hoffmann‐Vold,Michael Kreuter,Fernando J. Martínez,Justin M. Oldham,Claudia Valenzuela,Marlies Wijsenbeek,Yi Liu,Daniel Wachtlin, Susanne Stowasser,Donald F. Zoz,Luca Richeldi

Future rare diseases (2024)

引用0浏览0引用

Effectiveness of Methotrexate Versus Prednisone As First-Line Treatment for Pulmonary Sarcoidosis

Vivienne Kahlmann,Marcel Veltkamp, Karen Moor, Montse Janssen Bonas, Remy Mostard, Rein Van Rijswijk, Jan Van Der Maten, Miranda Geelhoed, Linda Moonen, Marieke Overbeek, Bart Koopman,Marco Grootenboers, Esther Nossent, Michiel Wagenaar, Henk Kramer, Pascal Wielders, René Jonkers, Stefan Walen, Brigitte Bogaarts, René Kerstens, Mayka Overgaauw, Jan Grutters,Marlies Wijsenbeek

Sarcoidosis and other granulomatous ILD/DPLD (2024)

引用0浏览0引用

Pneumotoxicity ASSociated with Rheumatological Drugs (PASSWRD) – A Modified Delphi